MENTIONS — KPG

Be the change you want to see in the world

ABS has developed a proprietary stenting technology designed to treat bifurcation lesions

KPG Capital & CoMay 18, 2025

Adrenas Therapeutics is dedicated to transforming the treatment landscape for adrenal insufficiency

KPG Capital & CoMay 18, 2025

ADP’s mission is to transform human resources from a traditional administrative

KPG Capital & CoMay 18, 2025

Adovate’s mission is to transform the treatment landscape for diseases involving adenosine receptors

KPG Capital & CoMay 18, 2025

Adolore Biotherapeutics’ mission is to revolutionize the treatment of chronic pain

KPG Capital & CoMay 18, 2025

adMare BioInnovations is committed to accelerating the advancement of life science technologies

KPG Capital & CoMay 18, 2025

Adiso Therapeutics’ mission is to discover and develop breakthrough therapies

KPG Capital & CoMay 18, 2025

Actinium Pharmaceuticals’ mission is to develop and commercialize targeted radiotherapy treatments

KPG Capital & CoMay 18, 2025

Acorda’s pipeline includes several innovative therapies aimed at treating neurological disorders

KPG Capital & CoMay 18, 2025

Aclairo’s team is composed of highly skilled professionals who bring a wealth of knowledge and expertise

KPG Capital & CoMay 18, 2025

Acer Therapeutics’ mission is to improve patient outcomes by delivering innovative therapies

KPG Capital & CoMay 18, 2025

AceLink’s team is composed of professionals with deep understanding and experience in glycolipid biology

KPG Capital & CoMay 18, 2025

Acceligen’s mission is to advance livestock genetics through precision breeding

KPG Capital & CoMay 18, 2025

Acadia is driven by a passion to address conditions that lack effective treatments

KPG Capital & CoMay 18, 2025

Abgenix’s most significant contribution to biotechnology was its proprietary XenoMouse technology

KPG Capital & CoMay 18, 2025

Abcuro presented initial results from a Phase 1 open label trial of ABC008 in IBM at the American

KPG Capital & CoMay 18, 2025

Abcentra’s mission is to develop and deliver breakthrough therapies that target the underlying mechanisms

KPG Capital & CoMay 18, 2025

Abalone Bio is dedicated to developing novel gene therapies that target the underlying genetic

KPG Capital & CoMay 18, 2025

A2A Pharmaceuticals is committed to leveraging cutting edge computational systems

KPG Capital & CoMay 18, 2025

7 Hills Pharma is dedicated to revolutionizing the treatment of drug resistant solid tumors

KPG Capital & CoMay 18, 2025